Hudson Capital Management LLC

Position in MRK — Merck & Co., Inc.

CIK 1727342 RAMSEY, NJ

Position in MRK

as of Jun 30, 2026 · filed Jul 14, 2026 Compact

Position Value

$282,186

+$19,714 QoQ

Shares Held

2,196

+0.6% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.14%

of 13F equity value

Holder Rank

#3,218

of 3,769 holders

Holding Since

Sep 2023

9 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Hudson Capital Management LLC holds $13,852,767 across 5 Drug Manufacturers - General names. MRK ranks #4 (2.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GILD	Gilead Sciences, Inc.	52,947	$6,689,323
2	BMY	Bristol Myers Squibb Co	109,354	$6,300,977
3	NVS	Novartis AG	2,040	$319,708
4	MRK	Merck & Co., Inc. This page	2,196	$282,186
5	JNJ	Johnson & Johnson	1,026	$260,573

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$282,186	2,196	+0.6%	Shares	Sole	2026-07-14
2026-03-31	$262,472	2,182	0.0%	Shares	Sole	2026-04-13
2025-12-31	$229,677	2,182	-0.3%	Shares	Sole	2026-01-21
2024-12-31	$217,662	2,188	+10.1%	Shares	Sole	2025-01-17
2024-09-30	$225,757	1,988	-0.4%	Shares	Sole	2024-10-09
2024-06-30	$247,104	1,996	+0.4%	Shares	Sole	2024-07-16
2024-03-31	$262,316	1,988	0.0%	Shares	Sole	2024-04-19
2023-12-31	$216,731	1,988	-0.3%	Shares	Sole	2024-01-11
2023-09-30	$205,179	1,993	—	Shares	Sole	2023-10-27
No filing history on record for this holder in this stock.